Yale School of Medicine - Internal Medicine

Cafraglutide was effective with less frequent dosing than currently available medications that target GLP-1.

Elkady joins the program to discuss her experience transitioning from patient care to clinical trials and industry.

In a new study, Yale researchers develop a method that has the potential to cure cystic fibrosis prior to birth.

A clinician performing an echocardiogram of a patient's heart

The Yale Biomedical Imaging Institute will drive transformative advancements in both basic science and clinical translation.

Yale researchers developed an AI model that illuminates critical details about—and possible treatments for—idiopathic pulmonary fibrosis. It could do so for many other diseases.

This Month in Review summary includes a list of some of the most impactful news in the dermatology space from June 2025.

A new study reveals how removing cysteine from diets transforms fat storage into fat burning, offering insights for improved health and longevity.

Yale researchers explore the risks and benefits of higher buprenorphine doses for opioid use disorder, aiming to improve treatment outcomes for veterans.

A new Yale study advances the ability of genome engineers to edit multiple DNA sites by threefold, and helps prevent unwanted mutations in the process.

A new Yale study investigates how artificial intelligence might help identify patients at risk of developing agitation in the emergency department.

Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 notable dermatology updates from the 2025 Revolutionizing Atopic Dermatitis (RAD) Conference.

These data from RAD 2025 highlight upadacitinib’s efficacy in the phase 3 Measure Up 1 and 2 studies for older adults with atopic dermatitis.

This Q&A interview at RAD 2025 features a discussion about a talk titled ‘Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis.’

Melinda Gooderham, MD, MSc, joins The Medical Sisterhood to discuss balancing mentorship, leadership, and family, as well as the empowerment of women in the medical field.

In this interview with Shahriari at RAD 2025, she highlights some of the most significant burdens that patients and caregivers face with atopic dermatitis.

Yale researchers reveal how geographic factors impact health risks for older Americans, highlighting disparities in mortality and disability rates.

Despite the effectiveness of weight loss medications like Ozempic and Wegovy, only 3% of eligible adults receive prescriptions, highlighting significant disparities.

Yale researchers unveil a groundbreaking 3D-bioprinted synthetic aorta, promising revolutionary advancements in cardiovascular disease treatment and patient care.

Researchers uncover a mechanism of insulin resistance in obese adolescents, paving the way for potential interventions to prevent type 2 diabetes.

New research suggests intensive blood pressure management may significantly benefit adults aged 80 and older, challenging previous treatment assumptions.

Iron deficiency affects millions globally, especially women, yet remains underdiagnosed. Regular screening can prevent severe health issues and improve lives.

Amy Spizuoco, DO, joins the show to discuss her journey as a key opinion leader in dermatology.

In this interview, Mona Shahriari, MD, and Raj Chovatiya, MD, PhD, touched on the evolving role of pharmacists and internal medicine doctors in atopic dermatitis.

In this interview, Christopher Bunick, MD, PhD, speaks on the elements of the RAD 2025 conference that he is most anticipating.

In this interview, Chovatiya and Shahriari highlight notable elements of the upcoming Revolutionizing Atopic Dermatitis (RAD) Conference.

Jennifer Soung, MD, joins The Medical Sisterhood to discuss her journey to launching LEADderm and how owning the podium has changed her career.

Mona Shahriari, MD, previews the upcoming Revolutionizing Atopic Dermatitis Annual Meeting being held in Nashville, TN from June 06-07.

A pair of experts discuss unmet needs and educational gaps related to atopic dermatitis.